524400
ISHITADR
Invest Now
Start SIP in
ISHITADR
Performance
- Low
- ₹76
- High
- ₹80
- 52 Week Low
- ₹62
- 52 Week High
- ₹105
- Open Price₹80
- Previous Close₹79
- Volume1,025
Investment Returns
- Over 1 Month -1.86%
- Over 3 Month -2.6%
- Over 6 Month -14.79%
- Over 1 Year + 21.99%
Smart Investing Starts Here Start SIP with Ishita Drugs & Industries for Steady Growth!
Ishita Drugs & Industries Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.
- P/E Ratio
- 27.2
- PEG Ratio
- 1.7
- Market Cap Cr
- 24
- P/B Ratio
- 2.2
- Average True Range
- 4.63
- EPS
- -
- Dividend Yield
- 0
- MACD Signal
- 1.14
- RSI
- 49.31
- MFI
- 54.84
Ishita Drugs & Industries Financials
Ishita Drugs & Industries Technicals
EMA & SMA
Current Price
₹79.00
-0.22
(-0.28%)

-
- Bearish Moving Average 13
-
- Bullish Moving Average 3
- 20 Day
- ₹80.19
- 50 Day
- ₹79.11
- 100 Day
- ₹79.20
- 200 Day
- ₹78.88
Resistance and Support
78.55
- R3 84.69
- R2 82.34
- R1 80.90
- S1 77.11
- S2 74.76
- S3 73.32
Ishita Drugs & Industries Corporate Actions - Bonus, Splits, Dividends
Date | Purpose | Remarks |
---|---|---|
2025-06-13 | Others | Inter-alia, to consider 1. To Update regarding the current business operations of the Company. 2. Other business matters. |
2025-05-30 | Audited Results | |
2025-02-13 | Quarterly Results | |
2024-11-12 | Quarterly Results | |
2024-08-13 | Quarterly Results |
Ishita Drugs & Industries F&O
About Ishita Drugs & Industries
- NSE Symbol
- ISHITADR
- BSE Symbol
- 524400
- Managing Director
- Mr. Jagdish Agrawal
- ISIN
- INE806D01016
Similar Stocks to Ishita Drugs & Industries
Ishita Drugs & Industries FAQs
Ishita Drugs & Industries share price is ₹79 As on 10 July, 2025 | 00:24
The Market Cap of Ishita Drugs & Industries is ₹23.6 Cr As on 10 July, 2025 | 00:24
The P/E ratio of Ishita Drugs & Industries is 27.2 As on 10 July, 2025 | 00:24
The PB ratio of Ishita Drugs & Industries is 2.2 As on 10 July, 2025 | 00:24
Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.